These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 19659774)

  • 1. Programmed death (PD)-1 molecule and its ligand PD-L1 distribution among memory CD4 and CD8 T cell subsets in human immunodeficiency virus-1-infected individuals.
    Rosignoli G; Lim CH; Bower M; Gotch F; Imami N
    Clin Exp Immunol; 2009 Jul; 157(1):90-7. PubMed ID: 19659774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of PD-L1, a marker of disease status, is not reduced by HAART in aviraemic patients.
    Rosignoli G; Cranage A; Burton C; Nelson M; Steel A; Gazzard B; Gotch F; Imami N
    AIDS; 2007 Jun; 21(10):1379-81. PubMed ID: 17545722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responsiveness of HIV-specific CD4 T cells to PD-1 blockade.
    Porichis F; Kwon DS; Zupkosky J; Tighe DP; McMullen A; Brockman MA; Pavlik DF; Rodriguez-Garcia M; Pereyra F; Freeman GJ; Kavanagh DG; Kaufmann DE
    Blood; 2011 Jul; 118(4):965-74. PubMed ID: 21652684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined Env- and Gag-specific T cell responses in relation to programmed death-1 receptor and CD4 T cell loss rates in human immunodeficiency virus-1 infection.
    Pettersen FO; Taskén K; Kvale D
    Clin Exp Immunol; 2010 Aug; 161(2):315-23. PubMed ID: 20491784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Programmed death 1 expression on HIV-specific CD4+ T cells is driven by viral replication and associated with T cell dysfunction.
    D'Souza M; Fontenot AP; Mack DG; Lozupone C; Dillon S; Meditz A; Wilson CC; Connick E; Palmer BE
    J Immunol; 2007 Aug; 179(3):1979-87. PubMed ID: 17641065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression.
    Day CL; Kaufmann DE; Kiepiela P; Brown JA; Moodley ES; Reddy S; Mackey EW; Miller JD; Leslie AJ; DePierres C; Mncube Z; Duraiswamy J; Zhu B; Eichbaum Q; Altfeld M; Wherry EJ; Coovadia HM; Goulder PJ; Klenerman P; Ahmed R; Freeman GJ; Walker BD
    Nature; 2006 Sep; 443(7109):350-4. PubMed ID: 16921384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Could a loss of memory T cells limit responses to hepatitis C virus (HCV) antigens in blood leucocytes from patients chronically infected with HCV before and during pegylated interferon-alpha and ribavirin therapy?
    Lee S; Hammond T; Watson MW; Flexman JP; Cheng W; Fernandez S; Price P
    Clin Exp Immunol; 2010 Jul; 161(1):118-26. PubMed ID: 20408862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skewed maturation of memory HIV-specific CD8 T lymphocytes.
    Champagne P; Ogg GS; King AS; Knabenhans C; Ellefsen K; Nobile M; Appay V; Rizzardi GP; Fleury S; Lipp M; Förster R; Rowland-Jones S; Sékaly RP; McMichael AJ; Pantaleo G
    Nature; 2001 Mar; 410(6824):106-11. PubMed ID: 11242051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential impact of PD-1 and/or interleukin-10 blockade on HIV-1-specific CD4 T cell and antigen-presenting cell functions.
    Porichis F; Hart MG; Zupkosky J; Barblu L; Kwon DS; McMullen A; Brennan T; Ahmed R; Freeman GJ; Kavanagh DG; Kaufmann DE
    J Virol; 2014 Mar; 88(5):2508-18. PubMed ID: 24352453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural suppression of human immunodeficiency virus type 1 replication is mediated by transitional memory CD8+ T cells.
    Killian MS; Johnson C; Teque F; Fujimura S; Levy JA
    J Virol; 2011 Feb; 85(4):1696-705. PubMed ID: 21147929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of PD-1 as a unique marker for failing immune reconstitution in HIV-1-infected patients on treatment.
    Grabmeier-Pfistershammer K; Steinberger P; Rieger A; Leitner J; Kohrgruber N
    J Acquir Immune Defic Syndr; 2011 Feb; 56(2):118-24. PubMed ID: 20980914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-mediated phosphatidylinositol 3-kinase/serine-threonine kinase activation in APCs leads to programmed death-1 ligand upregulation and suppression of HIV-specific CD8 T cells.
    Muthumani K; Shedlock DJ; Choo DK; Fagone P; Kawalekar OU; Goodman J; Bian CB; Ramanathan AA; Atman P; Tebas P; Chattergoon MA; Choo AY; Weiner DB
    J Immunol; 2011 Sep; 187(6):2932-43. PubMed ID: 21856939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulated proliferative responses in vertically HIV-infected children on HAART correlate with clinical and immunological markers.
    Resino S; Abad ML; Navarro J; Bellón JM; Sánchez-Ramón S; Angeles Muñoz-Fernández M
    Clin Exp Immunol; 2003 Jan; 131(1):130-7. PubMed ID: 12519396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of the CD8
    Li J; Huang HH; Tu B; Zhou MJ; Hu W; Fu YL; Li XY; Yang T; Song JW; Fan X; Jiao YM; Xu RN; Zhang JY; Zhou CB; Yuan JH; Zhen C; Shi M; Wang FS; Zhang C
    Front Immunol; 2021; 12():687296. PubMed ID: 34177939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. siRNA knockdown of PD-L1 and PD-L2 in monocyte-derived dendritic cells only modestly improves proliferative responses to Gag by CD8(+) T cells from HIV-1-infected individuals.
    Breton G; Yassine-Diab B; Cohn L; Boulassel MR; Routy JP; Sékaly RP; Steinman RM
    J Clin Immunol; 2009 Sep; 29(5):637-45. PubMed ID: 19562472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent human immunodeficiency virus-1 antigenaemia affects the expression of interleukin-7Ralpha on central and effector memory CD4+ and CD8+ T cell subsets.
    Mercier F; Boulassel MR; Yassine-Diab B; Tremblay C; Bernard NF; Sekaly RP; Routy JP
    Clin Exp Immunol; 2008 Apr; 152(1):72-80. PubMed ID: 18279439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of PD-L1 inhibition effects for HIV-infected individuals.
    Zheltkova V; Argilaguet J; Peligero C; Bocharov G; Meyerhans A
    PLoS Comput Biol; 2019 Nov; 15(11):e1007401. PubMed ID: 31693657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T(EMRA) cells in early infection are linked to control of HIV-1 viremia and predict the subsequent viral load set point.
    Northfield JW; Loo CP; Barbour JD; Spotts G; Hecht FM; Klenerman P; Nixon DF; Michaëlsson J
    J Virol; 2007 Jun; 81(11):5759-65. PubMed ID: 17376902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia.
    Brusa D; Serra S; Coscia M; Rossi D; D'Arena G; Laurenti L; Jaksic O; Fedele G; Inghirami G; Gaidano G; Malavasi F; Deaglio S
    Haematologica; 2013 Jun; 98(6):953-63. PubMed ID: 23300177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-L1 Blockade Differentially Impacts Regulatory T Cells from HIV-Infected Individuals Depending on Plasma Viremia.
    Peligero C; Argilaguet J; Güerri-Fernandez R; Torres B; Ligero C; Colomer P; Plana M; Knobel H; García F; Meyerhans A
    PLoS Pathog; 2015 Dec; 11(12):e1005270. PubMed ID: 26633181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.